Zobrazeno 1 - 10
of 461
pro vyhledávání: '"PUISSET, F."'
Autor:
Lefebvre, C., Martin, E., Hendriks, L.E.L., Veillon, R., Puisset, F., Mezquita, L., Ferrara, R., Sabatier, M., Filleron, T., Dingemans, A.-M.C., Besse, B., Raherisson, C., Mazières, J.
Publikováno v:
In Respiratory Medicine and Research November 2020 78
Autor:
Puisset F; AP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; Centre de Recherches en Cancérologie de Toulouse (CRCT), Team 14, INSERM UMR1037, Université de Toulouse, 2 avenue Hubert Curien, CS53717, Toulouse France; Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, Toulouse., Raffoux E; AP-HP, Hôpital Saint-Louis, Department of Haematology, Paris France, INSERM U944., Ades L; AP-HP, Hôpital Saint-Louis, Department of Senior Haematology, Paris France, INSERM U944., Huynh T; AP-HP, Hôpital Saint-Louis, Department of Senior Haematology, Paris France, INSERM U944., Itzykson R; AP-HP, Hôpital Saint-Louis, Department of Haematology, Paris France, INSERM U944., Bouscary D; AP-HP, Hôpital Cochin, Department of Haematology, Paris., Aguinana L; AP-HP, Hôpital Saint-Louis, Department of Senior Haematology, Paris France, INSERM U944., Rabian F; AP-HP, Hôpital Saint-Louis, Department of Haematology, Paris France, INSERM U944., Sebert M; AP-HP, Hôpital Saint-Louis, Department of Senior Haematology, Paris France, INSERM U944., Vekhoff A; AP-HP, Hôpital Saint-Antoine, Department of Haematology, Paris., Brissot E; AP-HP, Hôpital Saint-Antoine, Department of Haematology, Paris., Mohty M; AP-HP, Hôpital Saint-Antoine, Department of Haematology, Paris., Bonnin A; AP-HP, Hôpital Saint-Antoine, Department of Haematology, Paris., Genthon A; AP-HP, Hôpital Saint-Antoine, Department of Haematology, Paris., Zerbit J; AP-HP, Hôpital Cochin, Department of Haematology, Paris France; AP-HP, Department of Pharmacy, Paris Public Hospital at Home, Paris., Willems L; AP-HP, Hôpital Cochin, Department of Haematology, Paris., Decrocq J; AP-HP, Hôpital Cochin, Department of Haematology, Paris., Contejean A; AP-HP, Hôpital Cochin, Department of Haematology, Paris., Lengline E; AP-HP, Hôpital Saint-Louis, Department of Haematology, Paris France, INSERM U944., Mourah S; AP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; INSERM U976, Université Paris Cité, Paris., Goldwirt L; AP-HP, Hôpital Saint-Louis, Department of Pharmacology, Paris, France; INSERM U976, Université Paris Cité, Paris. lauriane.goldwirt@aphp.fr.
Publikováno v:
Haematologica [Haematologica] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.
Autor:
Blanchet B; Université de Paris, CNRS, INSERM, CiTCoM, U1268, F-75006, Paris, France. benoit.blanchet@aphp.fr.; Biologie du Médicament - Toxicologie, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France. benoit.blanchet@aphp.fr.; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France. benoit.blanchet@aphp.fr., Xu-Vuilard A; Department of Medical Oncology, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Georges Pompidou, Paris, France., Jouinot A; Department of Medical Oncology, ARIANE, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, Inserm U1016, CNRS UMR8104, Paris, France., Puisset F; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France., Combarel D; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.; Faculté de pharmacie, Université Paris Saclay, Orsay, France.; Medical School, University of Paris XI, Saclay, France., Huillard O; Department of Medical Oncology, ARIANE, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France., Le Louedec F; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France., Thomas F; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France.; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, 31037, Toulouse, France., Teixeira M; Department of Oncological Medicine, Gustave Roussy, Villejuif, France.; Medical School, University of Paris XI Saclay, Saclay, France., Flippot R; Department of Oncological Medicine, Gustave Roussy, Villejuif, France.; Medical School, University of Paris XI Saclay, Saclay, France.; Laboratoire d'immunomonitoring en oncologie, CNRS3655 & INSERM US23, Université Paris Saclay, Paris, France., Mourey L; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France., Albiges L; Department of Oncological Medicine, Gustave Roussy, Villejuif, France.; Medical School, University of Paris XI Saclay, Saclay, France., Pudlarz T; Department of Medical Oncology, Assistance Publique Hôpitaux de Paris, Hôpital Saint Antoine, Paris, France., Joly C; Department of Medical Oncology, Assistance Publique Hôpitaux de Paris, Hôpital Henri Mondor, Université de Paris Est, Créteil, France., Tournigand C; Department of Medical Oncology, Assistance Publique Hôpitaux de Paris, Hôpital Henri Mondor, Université de Paris Est, Créteil, France., Chauvin J; Lixoft, 92160, Antony, France., Puszkiel A; Biologie du Médicament - Toxicologie, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Université Paris Cité, Inserm, UMR-S1144, Paris, France., Chatelut E; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France.; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, 31037, Toulouse, France., Decleves X; Biologie du Médicament - Toxicologie, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Université Paris Cité, Inserm, UMR-S1144, Paris, France., Vidal M; Université de Paris, CNRS, INSERM, CiTCoM, U1268, F-75006, Paris, France.; Biologie du Médicament - Toxicologie, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France., Goldwasser F; Department of Medical Oncology, ARIANE, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France., Oudard S; Department of Medical Oncology, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Georges Pompidou, Paris, France.; Université de Paris Cité, INSERM U970, PARCC, Paris, France., Medioni J; Department of Medical Oncology, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Georges Pompidou, Paris, France., Vano YA; Department of Medical Oncology, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Georges Pompidou, Paris, France.; Université de Paris Cité, UMR_S1138-INSERM, Paris, France.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Apr; Vol. 130 (6), pp. 961-969. Date of Electronic Publication: 2024 Jan 25.
Autor:
Puisset F; Centre de Recherches en Cancérologie de Toulouse (CRCT), Team 14, INSERM UMR1037, Université de Toulouse, 2 avenue Hubert Curien, CS53717, Toulouse, France.; Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, Toulouse, France., Le Louedec F; Centre de Recherches en Cancérologie de Toulouse (CRCT), Team 14, INSERM UMR1037, Université de Toulouse, 2 avenue Hubert Curien, CS53717, Toulouse, France., Dalenc F; Medical Oncology Department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, Toulouse, France., Verguet L; Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, Centre Hospitalier Universitaire, Toulouse, France., De Maio E; Medical Oncology Department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, Toulouse, France., Lacaze JL; Medical Oncology Department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, Toulouse, France., Montastruc M; Medical Oncology Department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, Toulouse, France., Ung M; Medical Oncology Department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, Toulouse, France., Vinson C; Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, Toulouse, France., Perriat S; Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, Centre Hospitalier Universitaire, Toulouse, France., Pacher S; Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, Centre Hospitalier Universitaire, Toulouse, France., Chatelut E; Centre de Recherches en Cancérologie de Toulouse (CRCT), Team 14, INSERM UMR1037, Université de Toulouse, 2 avenue Hubert Curien, CS53717, Toulouse, France., Koning MW; Centre de Recherches en Cancérologie de Toulouse (CRCT), Team 14, INSERM UMR1037, Université de Toulouse, 2 avenue Hubert Curien, CS53717, Toulouse, France.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Jul; Vol. 89 (7), pp. 2283-2294. Date of Electronic Publication: 2023 Mar 20.
Autor:
Le Louedec F; Institut Claudius-Regaud, Institut Universitaire du Cancer Toulouse, Oncopole, 31059, Toulouse, France.; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, Toulouse, France., Puisset F; Institut Claudius-Regaud, Institut Universitaire du Cancer Toulouse, Oncopole, 31059, Toulouse, France.; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, Toulouse, France., Chatelut E; Institut Claudius-Regaud, Institut Universitaire du Cancer Toulouse, Oncopole, 31059, Toulouse, France. chatelut.etienne@iuct-oncopole.fr.; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, Toulouse, France. chatelut.etienne@iuct-oncopole.fr., Tod M; Hospices Civils de Lyon, GH Nord, Service de Pharmacie, 69004, Lyon, France.; Université Claude Bernard Lyon 1, UMR CNRS 5558, LBBE-Laboratoire de Biométrie et Biologie Évolutive, 69622, Villeurbanne, France.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2023 Jan; Vol. 62 (1), pp. 55-66. Date of Electronic Publication: 2023 Jan 11.
Publikováno v:
In Le Pharmacien Clinicien June 2024 59(2):e199-e199
Publikováno v:
In Le Pharmacien Clinicien June 2024 59(2):e61-e62
Autor:
Boumaza X; Service de Médecine Interne Purpan, Centre Hospitalier Universitaire de Toulouse, France; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Toulouse, France. Electronic address: boumaza.x@chu-toulouse.fr., Lafaurie M; Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire de Toulouse, France; Centre d'Investigation Clinique 1436, Equipe PEPSS, Centre Hospitalier Universitaire de Toulouse, INSERM, Toulouse, France., Treiner E; Laboratoire d'Immunologie, Institut Fédératif de Biologie, Centre Hospitalier Universitaire de Toulouse, France; Centre de Physiopathologie de Toulouse-Purpan, Centre Hospitalier Universitaire de Toulouse, France., Walter O; Service de Médecine Interne Purpan, Centre Hospitalier Universitaire de Toulouse, France; Centre d'Investigation Clinique 1436, Equipe PEPSS, Centre Hospitalier Universitaire de Toulouse, INSERM, Toulouse, France., Pugnet G; Service de Médecine Interne et immunologie clinique Rangueil, Centre Hospitalier Universitaire de, Toulouse, France., Martin-Blondel G; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Toulouse, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, France., Biotti D; Service de Neurologie, Centre Hospitalier Universitaire de Toulouse, France., Ciron J; Service de Neurologie, Centre Hospitalier Universitaire de Toulouse, France., Constantin A; Service de Rhumatologie, Centre Hospitalier Universitaire de Toulouse, France., Tauber M; Service de Dermatologie, Centre Hospitalier Universitaire de Toulouse, France., Puisset F; Service de Pharmacologie, Institut Universitaire du Cancer Oncopole, France., Moulis G; Service de Médecine Interne Purpan, Centre Hospitalier Universitaire de Toulouse, France; Centre d'Investigation Clinique 1436, Equipe PEPSS, Centre Hospitalier Universitaire de Toulouse, INSERM, Toulouse, France., Alric L; Service de Médecine Interne et immunologie clinique Rangueil, Centre Hospitalier Universitaire de, Toulouse, France., Renaudineau Y; Laboratoire d'Immunologie, Institut Fédératif de Biologie, Centre Hospitalier Universitaire de Toulouse, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, France., Chauveau D; Service de Néphrologie et Transplantation d'Organes, Centre de Référence Maladies Rénales Rares, Centre Hospitalier Universitaire de Toulouse, France., Sailler L; Service de Médecine Interne Purpan, Centre Hospitalier Universitaire de Toulouse, France; Centre d'Investigation Clinique 1436, Equipe PEPSS, Centre Hospitalier Universitaire de Toulouse, INSERM, Toulouse, France.
Publikováno v:
International immunopharmacology [Int Immunopharmacol] 2023 Jul; Vol. 120, pp. 110342. Date of Electronic Publication: 2023 Jun 03.
Autor:
Laloi L; Department of Pharmacy, Centre Léon Bérard, Lyon, France., Billotey NC; Department of Pharmacy, Centre Léon Bérard, Lyon, France., Dumas PY; Department of Hematology, University Hospital of Bordeaux, Bordeaux, France., Paul F; Department of Hematology, University Hospital of Montpellier, Montpellier, France., Villate A; Department of Hematology, University Hospital of Tours, Tours, France., Simand C; Department of Hematology, University Hospital of Strasbourg, Strasbourg, France., Fornecker L; Department of Hematology, University Hospital of Strasbourg, Strasbourg, France., Puisset F; Department of Pharmacy, Institut Universitaire du Cancer Oncopole, Toulouse, France., Bertoli S; Department of Hematology, Institut Universitaire du Cancer Oncopole, Toulouse, France., Simonet MB; Department of Hematology, University Hospital of Besançon, Besançon, France., Laribi K; Department of Hematology, Hospital of Le Mans, Le Mans, France., Houyou D; Department of Clinical Research, Hospital of Troyes, Troyes, France., Santagostino A; Department of Hematology, Hospital of Troyes, Troyes, France., Michel C; Department of Hematology, University Hospital of Nancy, Nancy, France., Guepin GR; Department of Hematology, University Hospital of Nancy, Nancy, France., Guerineau E; Department of Clinical Research, Hospital of Mont de Marsan, Mont de Marsan, France., Tabrizi R; Department of Hematology, Hospital of Mont de Marsan, Mont de Marsan, France., Hunault M; Department of Hematology, University Hospital of Angers, Angers, France., Giltat A; Department of Hematology, University Hospital of Angers, Angers, France., Kaphan E; Department of Hematology, University Hospital of Grenoble, Grenoble, France., Bulabois C; Department of Hematology, University Hospital of Grenoble, Grenoble, France., Cartet E; Department of Pharmacy, Hospital of Bourgoin-Jallieu, Bourgoin-Jallieu, France., Rocher C; Department of Hematology, Hospital of Bourgoin-Jallieu, Bourgoin-Jallieu, France., Lachenal F; Department of Hematology, Hospital of Bourgoin-Jallieu, Bourgoin-Jallieu, France., Morisset S; Independent Biostatistician, Pérouges, France., Récher C; Department of Hematology, Institut Universitaire du Cancer Oncopole, Toulouse, France., Pigneux A; Department of Hematology, University Hospital of Bordeaux, Bordeaux, France., Belhabri A; Department of Hematology and Medical Oncology, Centre Léon Bérard, Lyon, France., Michallet M; Department of Hematology and Medical Oncology, Centre Léon Bérard, Lyon, France., Michallet AS; Department of Hematology and Medical Oncology, Centre Léon Bérard, Lyon, France.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (6), pp. 7175-7181. Date of Electronic Publication: 2022 Dec 08.
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer.
Autor:
Puisset F; Institut Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059 Toulouse, France.; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, 31037 Toulouse, France., Mseddi M; Department of Pharmacokinetics and Pharmacochemistry, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris, CARPEM, 75014 Paris, France., Mourey L; Institut Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059 Toulouse, France., Pouessel D; Institut Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059 Toulouse, France., Blanchet B; Department of Pharmacokinetics and Pharmacochemistry, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris, CARPEM, 75014 Paris, France.; UMR8038 CNRS, U1268 INSERM, Faculté de Pharmacie, Université Paris Cité, PRES Sorbonne Paris Cité, CARPEM, 75006 Paris, France., Chatelut E; Institut Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059 Toulouse, France.; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, 31037 Toulouse, France., Chevreau C; Institut Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059 Toulouse, France.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Jan 03; Vol. 15 (1). Date of Electronic Publication: 2023 Jan 03.